Clinical Trial Update: CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CART-PSMA-TGFβRDN cells targeting prostate cancer; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• CART-PSMA-TGFβRDN Cells

Snippet

Sponsor: University of Pennsylvania | Conditions: Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING